Will new review system fix Hong Kong’s civil service? Experts have doubts

Will new review system fix Hong Kong’s civil service? Experts have doubts

Hong Kong needs to completely overhaul its civil servant review mechanism rather than add another layer of assessment to the existing system if the administration wants to improve performance and governance, observers have said. While one lawmaker said the government should implement clear assessment criteria for civil servants, others stressed that objective performance measures for…

Read More
Books about June 4 Tiananmen Square crackdown grow scarce in Hong Kong

Books about June 4 Tiananmen Square crackdown grow scarce in Hong Kong

Books about the Tiananmen Square crackdown have become increasingly scarce in Hong Kong’s independent bookstores, with sellers citing widespread self-censorship fuelled by legal uncertainties surrounding the sale of politically sensitive titles under the national security laws. The disappearance of the books and the loss of the annual June 4 candlelight vigil in Victoria Park, combined…

Read More
German scientist wins Hong Kong’s Shaw Prize for pioneering 3D imaging work

German scientist wins Hong Kong’s Shaw Prize for pioneering 3D imaging work

A German molecular biologist has won Hong Kong’s prestigious Shaw Prize this year for his development of a cutting-edge imaging technology that helps scientists understand how viruses attack the human body and come up with new treatments. Professor Wolfgang Baumeister, director emeritus and scientific member of the Max Planck Institute of Biochemistry in Germany, was…

Read More
Mainland Chinese drug effective in treating 3 cancer types: Hong Kong-led study

Mainland Chinese drug effective in treating 3 cancer types: Hong Kong-led study

A new drug developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options, a multinational study led by the Chinese University of Hong Kong (CUHK) has found. University researchers said on Monday that the novel drug, D3S-001, had shown “promising” results for treating non-small-cell…

Read More